Larger variability of office blood pressure (BP) was reportedly associated with a higher risk of stroke or mortality from all causes. In the present study, we focused on the relationship of variability of office BP and occurrence of acute myocardial infarction (MI). We registered 139 patients receiving antihypertensive therapy for more than 1 year who experienced first-ever episode of MI at the age of 60 years or over. At least two sex-and age-matched (؎5 years) control patients were registered for every MI patient. Average systolic and diastolic BP during the 12-month period prior to the occurrence of MI, or the time of registration in the case of control patients, was similar in both patient groups. The office BP variability was evaluated by calculating
Introduction
Cardiovascular disease is one of the leading causes of death and inability of elderly people. Hypertension is a major risk factor of cardiovascular diseases. Although antihypertensive therapy has decreased cardiovascular morbidity and mortality, the extent of the reduction of the cardiovascular risk is not enough. According to a recent meta-analysis of 17 randomised controlled trials, blood pressure (BP) lowering by 13/6 mm Hg for 4.9 years resulted in a 38% reduction of the risk of stroke and a 16% reduction of the risk of myocardial infarction (MI). 1 Larger circadian variation of BP 2, 3 and excessive BP fall during night time 4, 5 were associated with higher risk of cardiovascular events. A steep BP Correspondence: H Muratani, 207 Uehara, Nishihara-cho, Okinawa 903-0215, Japan. Fax: +81 98 895 1416 2 The cooperative study group on pathophysiology and treatment of elderly hypertension elevation around arousal, so-called morning surge, was suggested to have a causal relationship with the occurrence of acute MI. 6 Therefore, development of a therapeutic regimen to minimise circadian BP variability or to reduce the morning surge may be useful to further reduce the cardiovascular risk.
However, the relationship between long-term variability of BP and the occurrence of cardiovascular events has not been extensively examined. We recently demonstrated that larger variability of office BP was associated with a higher risk of stroke. 7 Larger long-term variability of systolic BP was associated with higher mortality from all causes in endstage renal disease patients undergoing haemodialysis. 8 In the present case-control study, we focused on the relationship between office BP variability and the occurrence of acute MI. We explored the effects on the risk of acute MI of long-term office BP variability in elderly patients receiving antihypertensive therapy.
Patients
This case-control study was performed at six hospitals where the members of the research group had out-patient clinics. We compared the clinical findings, laboratory data and prescribed drugs between the hypertensive patients who suffered from the first occurrence of MI after the age of 60 years and the age-and sex-matched hypertensive controls who did not have prior history of MI. All the data presented were of the pre-event period. If a patient met the following conditions, he or she was registered as a case patient for the present study: (1) under antihypertensive drug therapy for more than 1 year, (2) experienced first-ever episode of acute MI at the age of 60 years or over during a 10-year period between 1987 and 1996, and (3) office BP values measured at each visit were available for at least a 1-year period before the onset of the acute MI. At least 2 sexand age-matched (Ϯ5 years) control patients were registered for each case patient. The control patients were selected from the out-patients followed at the same hospital where the case patient was registered. The selection criteria for the control patients were the same as those for the case selection except that the patients had to be free from MI or stroke. The registration date of the control patient was determined as close as to the onset date of MI of each corresponding MI patient.
Diagnostic criteria of MI
The diagnosis of MI was based on the criteria in the World Health Organization Monitoring Trends and Determination in Cardiovascular Disease (WHO MONICA) project. 9 Both definite and possible MI were included.
BP measurement
At each visit, sitting BP was measured twice by the attending physician with a standard mercury sphygmomanometer. The average of the two readings was recorded for that day.
Inspection of the medical records
By investigating the medical records of the patients, office BP and pulse rate measured at each visit during a 1-year period before the onset of MI, classes of prescribed antihypertensive drugs, concomitant diseases including diabetes mellitus, hypercholesterolaemia and renal insufficiency, laboratory findings, and electrocardiographic findings were recorded on the registration sheets. As for the control patients, findings during a 1-year period prior to the registration date were recorded. Diabetes mellitus was diagnosed when the fasting plasma glucose concentration was 140 mg/dl or greater, when the diagnosis was confirmed by a 75 g oral glucose tolerance test, 10 or when the patient was receiving an oral hypoglycaemic agent or insulin. Hypercholesterolaemia was diagnosed when the serum total cholesterol concentration was 220 mg/dl or more, or when the patient was taking an antihypercholesterolaemic agent. Renal insufficiency was defined as a serum creatinine concentration у1.4 mg/dl for men and у1.2 mg/dl for women. These cut-off points were based on a previous report that showed that the risk of developing end-stage renal disease substantially increased when serum creatinine concentration exceeded these levels.
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Data analysis
Values are expressed as mean Ϯ standard deviation. The statistical analysis was performed with the use of the Statistical Analysis System (SAS). 12 Using multiple logistic analysis, we examined if the variability of office BP is a predictor of MI. P Ͻ 0.05 was considered statistically significant. The variability of office BP has been defined as the variation coefficient (VC) of office BP, which was calculated for each patient using the following formula; 100% (standard deviation of office BP measured at each visit) / (average of office BP).
Results
Characteristics of the MI and control patients
We registered 139 acute MI patients and 280 control patients. Clinical characteristics of the patients are shown in Table 1 . Body mass index of the MI patients was significantly lower than that of the control patients. Concerning the frequency of clinic visits, average values of systolic and diastolic BPs, percentage of patients with an average BP level Ͻ140/Ͻ90 mm Hg and average pulse rate value, there was no difference between the two groups of patients. The MI patients were more frequently accompanied by diabetes mellitus and prior angina pectoris. In the MI patients, frequency of current smoker and fasting plasma glucose concentrations were significantly higher than in the control patients. Frequency of hypercholesterolaemia and atrial fibrillation, serum creatinine, and total cholesterol concentrations were similar in the MI patients and the control patients. Beta-blocker was less frequently prescribed and nitrate was more frequently prescribed for the MI patients.
Office BP variability
The VC of office systolic BP during the 12-month period was similar in the MI patients (9.6 Ϯ 3.4%) and in the control patients (9.0 Ϯ 3.2%). The difference between the two groups of patients was not statistically significant. In contrast, the VC of office diastolic BP in the MI patients (10.0 Ϯ 4.0%) was significantly larger than that in the control patients (8.8 Ϯ 3.4%). The VC of diastolic BP was significantly higher in the MI patients compared with in the control patients, while the VC of systolic BP was not significantly different between the two groups of patients. Table 2 summarises the correlation coef- 
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ficients between the variability of office BP and other demographic and clinical findings. For this analysis, we combined the findings of the MI patients and the control patients. The VC of BP, irrespective of systolic or diastolic, was significantly related to age and diastolic BP level. The VC of diastolic BP was also significantly related to body mass index, heart rate, pulse pressure and serum total protein concentration. In addition, higher long-term variability of diastolic BP was associated with a prior history of angina pectoris and renal insufficiency ( Figure 1 ). There was no significant association between higher long-term variability of diastolic BP and diabetes mellitus, hypercholesterolaemia, or smoking. When 12-month average systolic BP у140 mm Hg or 12-month average diastolic BP у90 mm Hg, we regarded such patient as having inadequate BP control. Higher long-term variability of diastolic BP was also not associated with the inadequate BP control.
Multiple logistic analysis
We performed multiple logistic analysis in an attempt to detect factors related to the occurrence of acute MI. We tested a model which included age, sex, 12-month average diastolic BP or 12-month average pulse pressure, pulse rate, diabetes mellitus, smoking habit, angina pectoris, total cholesterol concentration, body mass index, serum creatinine, office diastolic BP variability, and the use of each drug as possible independent variables. As shown in Table 3 , when all patients were included in the analysis, in the model that included diastolic BP, the VC of diastolic BP, presence of diabetes mellitus, angina pectoris, and smoking habit were positively related to the occurrence of acute MI. The association of the VC of diastolic BP and the occurrence of acute MI was still significant in the analyses after excluding the patients with angina pectoris or excluding the patients with angina pectoris and renal insufficiency. When 12-month average systolic BP and systolic BP variability, instead of 12-month Figure 1 Comparison of variability of office diastolic blood pressure (BP) between the patients with a specific risk factor and those patients without the factor. In patients with renal insufficiency or angina pectoris, the variability of office diastolic BP, defined as the variation coefficient, was significantly larger compared with that in patients without renal insufficiency or angina pectoris, respectively. *P Ͻ 0.05. Inadequate BP control was defined as 12-month average systolic BP у140 mm Hg or 12-month average diastolic BP у90 mm Hg. average diastolic BP and office diastolic BP variability were included in the model, the VC of systolic BP was not a significant predictor of MI. When we included pulse pressure instead of diastolic BP in the model, the variability of DBP was not a significant predictor of MI in the analysis of all patients. However, when patients with angina pectoris or patients with angina pectoris and renal insufficiency were excluded from the analysis, the variability of diastolic BP was again detected as a significant predictor of MI in this model (Table 3) . Angina pectoris is an established predictor of MI. In the present study, highly significant association of higher VC of diastolic BP and angina pectoris was evident (Figure 1 ). Association of renal insufficiency was also more frequently (P Ͻ 0.05) observed in the MI patients than in the control patients (Table 1) . It is possible that angina pectoris and renal insufficiency are serious confounding factors that could not be appropriately adjusted using mathematical procedure. Therefore, we performed other sets of multiple logistic analyses to reconfirm the prognostic value of the BP variability after excluding those patients with angina pectoris or excluding those patients with angina pectoris and renal insufficiency. In these analyses, the variability of diastolic BP was significantly related to the risk of acute MI after adjustment for other possible confounding factors (Table 3) .
Discussion
In the present case-control study, larger variability of office diastolic BP expressed as the VC was significantly higher in the MI patients than in the control patients. The association of higher VC of diastolic BP with higher risk of acute MI was significant after adjustment for other confounding factors including diabetes mellitus, angina pectoris, smoking habit, and serum creatinine concentrations. This was true after excluding those patients with angina pectoris. The average BP level was similar in the MI patients and the control patients. Thus, long-term office diastolic BP variability may be an independent predictor of acute MI in the elderly patients receiving antihypertensive therapy.
Blood pressure variability and subsequent morbidity and mortality
Previous studies have reported controversial findings concerning the prognostic significance of shortterm BP variability and the occurrence of cardiac complications. A steep BP elevation around arousal, so-called morning surge, was associated with a higher risk of acute MI. 6 However, two studies 3, 13 failed to find a significant association between larger circadian amplitude of BP and subsequent cardiovascular morbidity or occurrence of coronary heart disease. Larger circadian BP variability 3 and excessive BP fall during the night time 4, 5 were associated with higher risk of stroke. In addition, the BP variability within 24 h successfully predicted aggravation of total end-organ damage in essential hypertensive patients. 2 Concerning the long-term variability of office BP, to our knowledge, only two studies have examined the relationship between variability of office BP and subsequent morbidity and mortality. Larger variability of office BP was associated with a higher risk of stroke in elderly hypertensive patients 7 and with higher mortality from all causes in end-stage renal disease patients undergoing haemodialysis. 8 These and the present findings suggest that long-term variability of BP predicts the risk of cardiovascular complications including stroke, MI, and mortality from all causes.
Mechanism of larger BP variability to increase the risk of acute MI
The mechanisms by which BP variability increases the risk of acute MI remain uncertain. However, several points deserve discussion. First, as well as in our previous study focusing on the relationship between the office BP variability and the risk of brain infarction, 7 the VC of diastolic BP positively correlated to age and pulse pressure. These findings suggest that larger variability of BP was a consequence of reduced compliance of large elastic arteries due to advanced arteriosclerosis. Stiffening of the large arterial wall attenuates the baroreflex function to cause a larger BP variability.
14 Another possibility is that larger office BP variability may reflect poorer adherence of patients to the drug therapy. According to the Government regulations, the drug prescription is limited to dosage for a maximum of one month in Japan. All patients registered in the present study were directed to visit the out-patient clinic every month. Less frequent visits meant irregular medication. However, in the present study, the frequency of hospital visits was similar in the MI patients and the control patients. Therefore, poorer adherence to the therapy may not explain the larger office BP variability observed in the MI patients.
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Study limitations
The present study has several limitations. First, the present study was a retrospective case-control study. It should be confirmed in future studies whether long-term BP variability actually predicts subsequent occurrence of MI. Second, patients with silent non-Q wave MI might have been included in the control group. Third, we did not examine the relationship between the circadian variation of BP and the long-term office BP variability. Some patients usually visited the clinic in the morning and other patients usually visited clinic in the afternoon. However, the exact time of clinic visit, ie the timing of BP measurement, was not strictly fixed. Therefore, the long-term variability of office BP would partly be affected by circadian variation of BP.
In conclusion, our present case-control study suggests that long-term variability of office diastolic BP is an independent predictor of MI in elderly hypertensive patients receiving antihypertensive drug therapy. Whether reducing the long-term variability of office BP would decrease the cardiovascular risk of the patients should be answered in future studies.
